Cargando…

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay

We assessed the ability of the BinaxNow rapid test to detect severe acute respiratory syndrome coronavirus 2 antigen from 4 individuals with Omicron and Delta infections. We performed serial dilutions of nasal swab samples, and specimens with concentrations of ≥100( )000 copies/swab were positive, d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regan, James, Flynn, James P, Choudhary, Manish C, Uddin, Rockib, Lemieux, Jacob, Boucau, Julie, Bhattacharyya, Roby P, Barczak, Amy K, Li, Jonathan Z, Siedner, Mark J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842316/ https://www.ncbi.nlm.nih.gov/pubmed/35169591 http://dx.doi.org/10.1093/ofid/ofac022

Ejemplares similares

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Accuracy of Expired BinaxNOW Rapid Antigen Tests
por: Vaeth, Mary Jane E., et al.
Publicado: (2023)

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern
por: Rao, Anuradha, et al.
Publicado: (2022)

The BinaxNOW pneumococcal antigen test: An adjunct for diagnosis of pneumococcal bacteraemia
por: Tootla, Hafsah D., et al.
Publicado: (2021)

Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting
por: Sood, Neeraj, et al.
Publicado: (2021)

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration
por: Frediani, Jennifer K., et al.
Publicado: (2021)

Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA
por: Surasi, Krishna, et al.
Publicado: (2021)

Diagnostic value of BinaxNOW antigen card for Severe Acute Respiratory Syndrome Coronavirus 2
por: Mai, Yue-Xue, et al.
Publicado: (2023)

Comparison of the ImmuView and the BinaxNOW antigen tests in detection of Streptococcus pneumoniae and Legionella pneumophila in urine
por: Athlin, S., et al.
Publicado: (2017)

366. Abbott BinaxNOW Rapid Antigen Test Performance in Detecting SARS-CoV-2 Infections in a COVID-19 Outbreak Among Horse Racetrack Workers
por: Surasi, Krishna, et al.
Publicado: (2021)

Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs
por: Landaverde, Lena, et al.
Publicado: (2022)

Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting
por: Okoye, Nkemakonam C., et al.
Publicado: (2021)

Comparison of Sofia Legionella FIA and BinaxNOW® Legionella urinary antigen card in two national reference centers
por: Beraud, L., et al.
Publicado: (2015)

Performance of BinaxNOW G6PD Deficiency Point-of-Care Diagnostic in P. vivax-Infected Subjects
por: Osorio, Lyda, et al.
Publicado: (2015)

Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening
por: Stokes, Nadarra L., et al.
Publicado: (2021)

Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020
por: Prince-Guerra, Jessica L., et al.
Publicado: (2021)

Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population
por: Pollreis, Rachel E., et al.
Publicado: (2021)

Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020
por: Almendares, Olivia, et al.
Publicado: (2022)

Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
por: Schrom, John, et al.
Publicado: (2023)

High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site during Prevalent Delta Variant Period
por: Sun, Kristie J., et al.
Publicado: (2022)

Comparison of a Prototype SARS-CoV-2 Lateral Flow IMMUNOASSAY with the BinaxNOW(TM) COVID-19 Antigen CARD
por: Hill, Haydon J., et al.
Publicado: (2022)

Implementation and Accuracy of BinaxNOW Rapid Antigen COVID-19 Test in Asymptomatic and Symptomatic Populations in a High-Volume Self-Referred Testing Site
por: Siddiqui, Zishan K., et al.
Publicado: (2021)

Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires’ disease or pneumococcal pneumonia and meningitis
por: Edelstein, Paul H., et al.
Publicado: (2020)

SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 antigen self tests
por: Nguyen, Phuong-Vi, et al.
Publicado: (2023)

Duration of viable virus shedding in SARS-CoV-2 omicron variant infection
por: Boucau, Julie, et al.
Publicado: (2022)

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
por: Boucau, Julie, et al.
Publicado: (2022)

Diagnostic utility of BINAX NOW RSV – an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence
por: Jonathan, Nteimam
Publicado: (2006)

Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
por: Pilarowski, Genay, et al.
Publicado: (2020)

Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
por: Siedner, Mark J., et al.
Publicado: (2022)

Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
por: Seaman, Michael S., et al.
Publicado: (2022)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
por: James, Allison E., et al.
Publicado: (2021)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Real-time PCR compared to Binax NOW and cytospin-immunofluorescence for detection of influenza in hospitalized patients
por: Landry, Marie L., et al.
Publicado: (2008)

Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
por: Seaman, Michael S., et al.
Publicado: (2022)

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)

SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy
por: Edelstein, Gregory E., et al.
Publicado: (2023)

Comparison of Binax NOW urine antigen test and pneumococcal DNA assay using qPCR before and after nasopharyngeal swabbing in healthy Malawian children
por: Lees, E.A., et al.
Publicado: (2015)

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021)

SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency
por: Li, Yijia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4271lmveq1ec4sss5ptvn2k9ob